Skip to main content
Lyrea avatar

Not yet reviewed — this article is pending editorial review by Lyrea.

Citation noticeOur citation system is being overhauled

References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.

Naphyrone

This article is a stubmissing:
Subjective Effects
Pharmacology
Interactions
Tolerance
History & Culture
Naphyrone molecule structureNaphyrone molecule structure
Naphthylpyrovalerone
O-2482, NRG-1, Energy-1, Rave
Psychoactive Class
Stimulant

Dosage & Duration

Dosage

Doses are population estimates that vary widely between individuals.

Moderate20-35 mg
Strong35-50 mg
Heavy50+ mg

Duration

Total6-12 hours

Subjective Effects

Subjective Effects not written up yet

Reagent Testing

Expected colorimetric results for common reagent tests. Colors show reaction change over 1–2 minutes.

Marquis(MQ)
white → yellow2 → green2
Mecke(ME)
white → orange3 → brown1
Mandelin(MD)
yellow2 → brown2
Liebermann(LB)
white → brown2
Powered by PROtestkit.eu

Pharmacology

Pharmacology not written up yet

Interactions

Interactions not written up yet

An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.

Check TripSit

Tolerance

Tolerance not written up yet

Harm Potential

Addiction & Dependence

Psychological

Classified as habit-forming. As a stimulant and triple reuptake inhibitor, psychological addiction potential is expected, though no specific data on naphyrone's addiction profile exists.

History & Culture

History & Culture not written up yet

Legality

By Country

Controlled / restricted1
Finland flagFinlandRestricted

References

Source Pages

  1. Erowid: Naphyrone Experience Reports
  2. Erowid: Naphyrone Vault
  3. TripSit: Drug Combination Chart
  4. Wikipedia

Citations

  1. Valtioneuvoston asetus 650/2026 kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista annetun valtioneuvoston asetuksen liitteen muuttamisesta. finlex.fi (n.d.). https://www.finlex.fi/api/media/statute/1073201/mainPdf/main.pdf1
  2. Huumausainelaki (373/2008), current consolidated text, section 5. finlex.fi (n.d.). https://www.finlex.fi/fi/lainsaadanto/2008/3731
  3. Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, original Finnish enactment. finlex.fi (n.d.). https://www.finlex.fi/api/media/statute/87257/mainPdf/main.pdf?timestamp=2014-12-19T00%3A00%3A00.000Z1
  4. Laki huumausainelain muuttamisesta 1127/2014, section 5. finlex.fi (n.d.). https://www.finlex.fi/api/media/statute/702487/mainPdf/main.pdf?timestamp=2014-12-18T22%3A00%3A00.000Z1

Further Reading

  1. 3DChem: Naphyrone Chemical Structure
  2. ACMD Report: Consideration of naphthylpyrovalerone analogues (2010)
  3. Brandt et al. (2010): The naphyrone story (DOI)
  4. Danda et al. (2022): Effects of naphyrone in CPP test (PubMed)
  5. DrugWise: Naphyrone 2010 Report
  6. DrugWise: Naphyrone Factsheet
  7. FRANK: Naphyrone Effects & Risks
  8. Pinterova-Leca et al. (2021): Pharmacokinetics and behavioural effects in rats (PubMed)
  9. Release: NRG-1, NRG-3, Naphyrone Information

Article Status

  • Josie Kins avatar
    Step 1 · Automated synthesis

    An autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.

  • Step 2 · First-pass reviewPending

    Not yet reviewed — this article is pending editorial review by Lyrea.

  • Step 3 · Citation reviewPending

    No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.

Recent changes7 human edits · latest

Times are UTCNewest first

24 January 2026

  1. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  2. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  3. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  4. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  5. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  6. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  7. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

All changes to this article · Site-wide recent changes

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the Naphyrone article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.